These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 28893793

  • 21. Deregulation of Genes Associated with Alternate Drug Resistance Mechanisms in Mycobacterium tuberculosis.
    Sriraman K, Nilgiriwala K, Saranath D, Chatterjee A, Mistry N.
    Curr Microbiol; 2018 Apr; 75(4):394-400. PubMed ID: 29143876
    [Abstract] [Full Text] [Related]

  • 22. Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors.
    Bosne-David S, Barros V, Verde SC, Portugal C, David HL.
    J Antimicrob Chemother; 2000 Sep; 46(3):391-5. PubMed ID: 10980165
    [Abstract] [Full Text] [Related]

  • 23. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis.
    Puech V, Guilhot C, Perez E, Tropis M, Armitige LY, Gicquel B, Daffé M.
    Mol Microbiol; 2002 May; 44(4):1109-22. PubMed ID: 12010501
    [Abstract] [Full Text] [Related]

  • 24. Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
    Pagliotto AD, Caleffi-Ferracioli KR, Lopes MA, Baldin VP, Leite CQ, Pavan FR, Scodro RB, Siqueira VL, Cardoso RF.
    J Microbiol Immunol Infect; 2016 Dec; 49(6):980-983. PubMed ID: 26454420
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
    Li W, Obregón-Henao A, Wallach JB, North EJ, Lee RE, Gonzalez-Juarrero M, Schnappinger D, Jackson M.
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5198-207. PubMed ID: 27297488
    [Abstract] [Full Text] [Related]

  • 26. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis.
    Alahari A, Alibaud L, Trivelli X, Gupta R, Lamichhane G, Reynolds RC, Bishai WR, Guerardel Y, Kremer L.
    Mol Microbiol; 2009 Mar; 71(5):1263-77. PubMed ID: 19183278
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
    Porvaznik I, Mokry J, Solovic I.
    Adv Exp Med Biol; 2015 Mar; 835():15-22. PubMed ID: 25252893
    [Abstract] [Full Text] [Related]

  • 30. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P, Jadaun GP, Das R, Gupta UD, Srivastava K, Chauhan A, Sharma VD, Chauhan DS, Katoch VM.
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [Abstract] [Full Text] [Related]

  • 31. EfpA is required for regrowth of Mycobacterium tuberculosis following isoniazid exposure.
    Roberts AH, Moon CW, Faulkner V, Kendall SL, Waddell SJ, Bacon J.
    Antimicrob Agents Chemother; 2024 Aug 07; 68(8):e0026124. PubMed ID: 39037241
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
    Zimenkov DV, Kulagina EV, Antonova OV, Surzhikov SA, Bespiatykh IuA, Shitikov EA, Il'ina EN, Mikhaĭlovich VM, Zasedatelev AS, Griadunov DA.
    Mol Biol (Mosk); 2014 Aug 07; 48(2):251-64. PubMed ID: 25850294
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J, Realpe T, Mejia GI, Zapata E, Rozo JC, Ferro BE, Robledo J.
    Antimicrob Agents Chemother; 2015 Dec 07; 59(12):7805-10. PubMed ID: 26369965
    [Abstract] [Full Text] [Related]

  • 36. Mycobacterium tuberculosis PhoY Proteins Promote Persister Formation by Mediating Pst/SenX3-RegX3 Phosphate Sensing.
    Namugenyi SB, Aagesen AM, Elliott SR, Tischler AD.
    mBio; 2017 Jul 11; 8(4):. PubMed ID: 28698272
    [Abstract] [Full Text] [Related]

  • 37. [The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones].
    Ergeshov A, Andreevskaya SN, Larionova EE, Smirnova TG, Chernousova LN.
    Mol Biol (Mosk); 2017 Jul 11; 51(4):595-602. PubMed ID: 28900077
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
    Zheng H, Williams JT, Coulson GB, Haiderer ER, Abramovitch RB.
    Antimicrob Agents Chemother; 2018 Jul 11; 62(7):. PubMed ID: 29661875
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.